Source: Investing.com ↗

Roivant to present phase 2 pulmonary hypertension study results

|

Translation unavailable. Please try again.

Original report

Read the original report on Investing.com ↗

Recommended markets

No specific asset was identified in this report; browse live USDT reference pairs.

Browse markets →

USDC/USDT

$1.00

-0.02%

BTC/USDT

$85,848.48

-0.09%

ETH/USDT

$2,734.40

-0.28%

ZEC/USDT

$1,649.04

+9.85%

XRP/USDT

$1.60

+4.21%